Allison Dorval - 29 Nov 2021 Form 3 Insider Report for Verve Therapeutics, Inc. (VERV)

Role: Chief Financial Officer
Signature: /s/ Andrew Ashe, Attorney-in-Fact
Issuer symbol: VERV
Transactions as of: 29 Nov 2021
Transactions value $: $0
Form type: 3
Filing time: 30 Nov 2021, 15:25:24 UTC
Previous filing: 16 Jul 2021
Next filing: 15 Feb 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit Index: 24.1 Power of Attorney